Medical Device Technologies (MDT) submits 510(k) for cell recovery system:
This article was originally published in Clinica
Medical Device Technologies (US) has submitted a 510(k) for its endoscopic cell recovery system (CRS). Initially marketing will be for bladder cancer detection but the CRS can be used in a number of endoscopic procedures to detect cancer on the inner surface of internal organs.
You may also be interested in...
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake - but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.
Alvotech has struck a major deal with Yangtze River Pharmaceutical that will allow eight of the biosimilars developer’s products to be commercialized in China.